Table 1 Antibiotic susceptibility profiling of the 4 clinical isolates

From: In-host evolution of Yersinia enterocolitica during a chronic human infection

Antibiogram

Class

Subclass

Antibiotic

Ye.1

Ye.2

Ye.3

Ye.4

β-lactam

penicillin (4 G)

piperacillin-tazobactam³

penicillin (4 G)

piperacillin

r

penicillin (4 G)

ticarcillin

R

R

R

R

penicillin (3 G)

amoxicillin

R

R

R

R

carbapenem

ertapenem

penicillin

ticarcillin-clavulanate

cephem (3 G)

ceftazidime

r

cephem (2 G)

cefoxitin

r

R

penicillin (4 G)

temocillin

r

carbapenem

imipenem

r

penicillin (3 G)

amoxicillin-clavulanate

r

cephem (3 G)

cefotaxime

r

cephem (3 G)

ceftazidime-avibactam

r

carbapenem

meropenem

monobactam

aztreonam

cephem (4 G)

cefepime

cephem (3 G)

moxalactam

r

penicillin

mecillinam

r

cephem (5 G)

ceftolozan-tazobactam

r

cephem

cefiderocol

r

quinolone

quinolone

nalidixic acid

R

R

fluoroquinolone

levofloxacin

fluoroquinolone

ciprofloxacin²

tetracycline

 

tigecycline

fosfomycin

 

fosfomycin

nitrofuran

 

nitrofurantoin

sulfonamide-trimethoprime

 

sulfamethoxazole-trimethoprim

amphenicol

 

chloramphenicol

polymyxin

 

colistin

aminoglycosides

 

gentamicin

 

amikacin³

 

tobramycin

 

netilmicin¹²

r

MIC

Class

Subclass

Antibiotic

Ye.1

Ye.2

Ye.3

Ye.4

β-lactam

cephem (3 G)

ceftriaxone¹²³

0.047

0.094

0.094

> 256

cephem (2 G)

cefoxitin

4

12

12

> 256

penicillin (4 G)

piperacillin-tazobactam³

0.094

0.25

<0.016

0.094

aminoglycosides and aminoglycosides-like

 

netilmicin¹²

0.75

3

0.064

0.064

 

amikacin³

3

3

2

1

 

tobramycin

1

1

0.094

0.094

 

gentamicin

0.5

1

0.094

0.094

 

spectinomycin

12

24

0.094

0.094

Quinolone

fluoroquinolone

ciprofloxacin² (Etest - MH)

0.008

0.012

0.002

0.032

fluoroquinolone

ciprofloxacin² (microdilution - LB)

0.015

0.03

0.125

0.5

fluoroquinolone

levofloxacin

0.032

0.032

0.008

0.032

  1. 1Administred treatment between Ye.1 and Ye.2 isolation.
  2. 2Administred treatment between Ye.2 and Ye.3 isolation.
  3. 3Administred treatment between Ye.3 and Ye.4 isolation.
  4. 3 G: 3rd generation. 4 G: 4th generation. 5 G: 5th generation. -: susceptible. R: resistance. r: increased resistance compared to previous strain. MH: Mueller-Hinton. LB: Lysogeny Broth. Source data are provided as a Source Data file.